Non-clinical safety evaluation of a novel pharmaceutical salt, rosuvastatin ethanolamine, in Wistar rats

Rosuvastatin, a second generation 3-Hydroxy-3-Methyl Glutaryl Coenzyme-A reductase inhibitor, is widely used for the management of hypercholesterolemia. Rosuvastatin ethanolamine, developed by Cadila Healthcare Ltd., is a novel, chemically stable, and pharmaceutically acceptable salt, having better...

Descripción completa

Detalles Bibliográficos
Autores principales: Vaghasiya, Jigneshkumar, Patel, Satyam, Patel, Sudhir, Kadam, Shekhar, Ranvir, Ramchandra, Patel, Harilal, Sundar, Rajesh, Jain, Mukul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Slovak Toxicology Society SETOX 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7061451/
https://www.ncbi.nlm.nih.gov/pubmed/32189982
http://dx.doi.org/10.2478/intox-2019-0002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7061451/
https://www.ncbi.nlm.nih.gov/pubmed/32189982
http://dx.doi.org/10.2478/intox-2019-0002

Ejemplares similares